Possible Mass Exodus Brewing At Gilead As Another Top Official Announces Departure

The moves add to a picture of growing investor unease over the health of large biotech companies, which are being pushed to find successors for aging blockbuster drugs. In other pharmaceutical news: Pfizer is investing in a better flu vaccine, a startup struggles to build interest by male doctors for a drug that benefits women; and a deeper look at CAR-T therapy.

from Kaiser Health News https://ift.tt/2nJK3R2